Keybank National Association Apellis Pharmaceuticals, Inc. Transaction History

Keybank National Association

  • $25.5 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024
BUY
$38.07 - $59.71 $33,463 - $52,485
879 Added 13.38%
7,449 $285,000
Q1 2024

May 14, 2024
BUY
$55.39 - $72.47 $1,163 - $1,521
21 Added 0.32%
6,570 $386,000
Q4 2023

Feb 13, 2024
BUY
$37.14 - $64.82 $243,229 - $424,506
6,549 New
6,549 $392,000
Q2 2022

Aug 08, 2022
BUY
$35.07 - $59.21 $293,641 - $495,765
8,373 New
8,373 $379,000

Others Institutions Holding APLS

# of Institutions
308
Shares Held
115M
Call Options Held
3.85M
Put Options Held
1.09M
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.64B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email